Advances in Psilocybin Research

Posted by

Analytical Cannabis

Watch this extended webinar which exclusively focused on the recent advances in psychedelic research for the use of psilocybin to satisfy unmet clinical needs and the regulations associated with this drug. Dr. Markus Roggen, President & Chief Science Officer of Delic Labs presented his talk: Structure, Activity & the Relationship Between the Emerging Psychedelic Industry and Unmet Medical Needs. Danielle St. Germaine, Scientist, Forensic Chemistry at Cayman Chemical Company, presented her talk: The Magic and Chemistry Behind Psychedelic Mushrooms